September 19, 2013

Clinical Trial: Evaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine in Patients With Melanoma (Mel 51)

Sponsor and Collaborators

University of Virginia

Contact
Sasha White, BS
434-982-1902

Kristy Scott, BS
434-982-6714

Principal Investigator
Craig L. Slingluff, M.D.

ClinicalTrials.gov Identifier
NCT00977145

Next post in Melanoma Clinical Trials

Want to read more?